CYP 2.13% 24.0¢ cynata therapeutics limited

Agree Finalisation of preclinical trials in the heart attack...

  1. 36 Posts.
    Agree

    Finalisation of preclinical trials in the heart attack study (Oct 2017?), asthma (corticosteroids) (Feb 2018?), and ARDS (???) also have potential to give the share price a kickstart.

    Lots of irons in the fire here
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $43.11M
Open High Low Value Volume
23.5¢ 24.0¢ 23.5¢ $14.74K 61.89K

Buyers (Bids)

No. Vol. Price($)
1 4000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 96221 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.005 ( 2.13 %)
Open High Low Volume
23.5¢ 24.0¢ 23.5¢ 6875
Last updated 10.47am 03/05/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.